شحن متتبَّع إلى جميع أنحاء العالم | خلال 9–14 يوم عمل تقريبًا

سلتك

سلة التسوق فارغة

ابدأ التصفح

شحن مجاني على الطلبات التي تزيد عن €500.

المجموع الفرعي€0
المتابعة إلى الدفع
التعافيما قبل السريري فقط

KPV

البحوث المنشورة وقاعدة الأدلة

KPV is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone, alpha-MSH(11-13). Its evidence base is entirely preclinical and is concentrated in gut inflammation, where oral or rectal delivery via the PepT1 di/tripeptide transporter reduces colitis severity in rodent models, and in topical or barrier-protective applications in keratinocytes. A substantial share of the recent literature is formulation science (nanoparticles, hydrogels, microneedles) rather than new pharmacology. There are no human trials of KPV for any indication.

باختصار
  • KPV هو ببتيد ثلاثي مشتق من هرمون تحفيز الخلايا الصبغية ألفا.
  • أفادت دراسات حيوانية بانخفاض شدة التهاب القولون ودرست دراسات خلوية التأثيرات على الخلايا الكيراتينية.
  • لم تُنشر أي تجارب بشرية لأي مؤشر.

17 دراسة · 6 منذ 2023 · الأحدث 2026

الدراسات المذكورة
17
منشورة 2023+
6
أحدث ورقة بحثية
2026
آخر مراجعة
أكتوبر 2026

المواضيع المتكررة في الأدبيات

  • NF-kappaB suppression and cytokine reduction
  • PepT1-mediated intestinal uptake
  • colitis and gut barrier repair
  • keratinocyte protection and skin inflammation
  • antimicrobial activity of alpha-MSH fragments
  • targeted oral and topical delivery systems

معرّفات المركب

CAS
67727-97-3
PubChem
125672

الحالة التنظيمية

موصى به من قبل لجنة استشارية تابعة لإدارة الغذاء والدواء.

في 23–24 July 2026 نظرت اللجنة الاستشارية للتركيب الصيدلاني التابعة لإدارة الغذاء والدواء في KPV لقائمة المواد الأولية 503A وأوصت بإضافته بتصويت مبلغ عنه بنتيجة 8–6 with one abstention. Heard as KPV free base and KPV acetate, and recommended on a divided vote.

هذا ليس موافقة. اللجنة تقدم المشورة؛ لا تتخذ القرارات. التوصية غير ملزمة، ولم تكمل إدارة الغذاء والدواء عملية سن القواعد التي من شأنها تغيير أي شيء رسمياً، والإدراج في قائمة المواد الأولية 503A لا يعادل موافقة إدارة الغذاء والدواء على دواء. القائمة تحكم أيضاً التركيب الصيدلاني للمرضى، وهو نشاط منفصل عن التوريد للاستخدام البحثي فقط.

ما فعله تصويت يوليو 2026 الاستشاري فعلياً يوضح العملية، والمركبات الأخرى التي نُظر فيها، والأمور الأربعة التي يُبلغ عن التصويت خطأً على أنها تعنيها.

الهوية الكيميائية

ما هو KPV، كيميائياً.

الصيغة الجزيئية
C16H30N4O4
الوزن الجزيئي
342.43 g/mol
رقم CAS
67727-97-3
PubChem CID
125672

هذه الأرقام مأخوذة من سجل PubChem لهذا المركب وتصف القاعدة الحرة. يتم توفير الببتيد المجفف بالتجميد عادةً كملح أسيتات أو ترايفلوروأسيتات ويحتوي على ماء متبقٍ، لذا فإن كتلة المسحوق في القارورة ليست نفس الكمية التي يشير إليها الوزن الجزيئي أعلاه. النقاء الكروماتوغرافي في شهادة التحليل لا يحل هذا الفرق أيضاً — كيفية قراءة شهادة التحليل يوضح السبب.

الأدلة

17 دراسة منشورة.

مرتبة حسب قوة تصميم الدراسة، ثم حسب الحداثة. كل إدخال يرتبط بالسجل المصدري حتى يمكن التحقق من النتيجة مقابل الورقة البحثية بدلاً من الاعتماد على كلامنا.

  1. 01حيواني داخل الجسم الحي2024

    KPV and RAPA Self-Assembled into Carrier-Free Nanodrugs for Vascular Calcification Therapy

    Zhang L, et al. · Adv Healthc Mater · carrier-free self-assembled KPV plus rapamycin nanodrug tested in vascular calcification models

    KPV and rapamycin self-assembled into a carrier-free nanodrug that reduced vascular calcification, avoiding the low drug-loading and safety limitations of conventional nanomedicine carriers.

  2. 02حيواني داخل الجسم الحي2024

    Growth Factors-Loaded Temperature-Sensitive Hydrogel as Biomimetic Mucus Attenuated Murine Ulcerative Colitis via Repairing the Mucosal Barriers

    Li D, et al. · ACS Appl Mater Interfaces · murine ulcerative colitis treated with a thermosensitive poloxamer hydrogel carrying hyaluronic acid, epigallocatechin-3-gallate, KPV tripeptide and epidermal growth factor

    The KPV-containing biomimetic mucus hydrogel attenuated murine ulcerative colitis by repairing the mucosal barrier.

  3. 03حيواني داخل الجسم الحي2021

    Self-Cross-Linked Hydrogel of Cysteamine-Grafted gamma-Polyglutamic Acid Stabilized Tripeptide KPV for Alleviating TNBS-Induced Ulcerative Colitis in Rats

    Sun J, et al. · ACS Biomater Sci Eng · TNBS-induced ulcerative colitis in rats; rectally administered KPV stabilised in a self-cross-linked thiolated gamma-polyglutamic acid hydrogel

    Free KPV solution was unstable on rectal administration, which compromised efficacy; the hydrogel-stabilised formulation alleviated TNBS-induced colitis in rats.

  4. 04حيواني داخل الجسم الحي2021

    In situ mucoadhesive hydrogel capturing tripeptide KPV: the anti-inflammatory, antibacterial and repairing effect on chemotherapy-induced oral mucositis

    Shao W, et al. · Biomater Sci · chemotherapy-induced oral mucositis model treated with a temperature-sensitive PLGA-PEG-PLGA hydrogel with epigallocatechin-3-gallate as adhesion enhancer, loaded with KPV

    The KPV-loaded mucoadhesive hydrogel produced anti-inflammatory, antibacterial and reparative effects on chemotherapy-induced oral mucositis.

  5. 05حيواني داخل الجسم الحي2017

    Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis

    Xiao B, et al. · Mol Ther · murine ulcerative colitis; KPV loaded into hyaluronic acid-functionalised polymeric nanoparticles (~272 nm) given orally

    Hyaluronic acid-functionalised nanoparticles mediated targeted delivery of KPV to inflamed colonic tissue and alleviated ulcerative colitis in mice more effectively than free peptide.

  6. 06حيواني داخل الجسم الحي2016

    Critical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of the anti-inflammatory PepT1-mediated tripeptide KPV in a murine model

    Viennois E, et al. · Cell Mol Gastroenterol Hepatol · AOM/DSS-induced colitis-associated cancer in mice overexpressing human PepT1 in intestinal epithelial cells and in PepT1-knockout mice

    PepT1 expression promoted colitis-associated cancer development, and PepT1-transported KPV reduced inflammation and tumour burden in the murine model.

  7. 07حيواني داخل الجسم الحي2013

    Single administration of tripeptide alpha-MSH(11-13) attenuates brain damage by reduced inflammation and apoptosis after experimental traumatic brain injury in mice

    Schaible EV, et al. · PLoS One · experimental traumatic brain injury in mice; single administration of alpha-MSH(11-13), with POMC, MC1R and MC4R mRNA profiling

    A single dose of the tripeptide attenuated brain damage after experimental traumatic brain injury, with reduced inflammation and apoptosis relative to controls.

  8. 08حيواني داخل الجسم الحي2008

    Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease

    Kannengiesser K, et al. · Inflamm Bowel Dis · two murine models of intestinal inflammation, including dextran sodium sulfate colitis

    KPV reduced intestinal inflammation in both murine models, supporting the melanocortin-derived tripeptide as an anti-inflammatory agent independent of the full alpha-MSH sequence.

  9. 09حيواني داخل الجسم الحي2008

    PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation

    Dalmasso G, et al. · Gastroenterology · human Caco2 intestinal epithelial cells and immune cells in vitro, plus two mouse colitis models

    KPV entered intestinal epithelial and immune cells via the PepT1 di/tripeptide transporter, and this transporter-mediated uptake accounted for its anti-inflammatory effect in mouse colitis. This established the mechanism underlying oral KPV dosing.

  10. 10حيواني داخل الجسم الحي2006

    Effects of the COOH-terminal tripeptide alpha-MSH(11-13) on corneal epithelial wound healing: role of nitric oxide.

    Bonfiglio V, et al. · Exp Eye Res · rabbit mechanical corneal epithelial abrasion model plus rabbit corneal epithelial cells

    Topical KPV accelerated corneal re-epithelialisation (all treated corneas closed at 60 h vs none with placebo); the effect was blocked by the NO synthase inhibitor L-NAME.

  11. 11حيواني داخل الجسم الحي2003

    Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides

    Getting SJ, et al. · J Pharmacol Exp Ther · murine crystal-induced peritonitis, comparing KPV with alpha-MSH, the core melanocortin peptide, an MC3/MC4 agonist and a selective MC1R agonist

    Systemic KPV significantly reduced leukocyte accumulation in crystal-induced peritonitis, as did alpha-MSH and the MC3/MC4 agonist, whereas the selective MC1R agonist did not. This separated KPV's anti-inflammatory action from MC1R signalling.

  12. 12في المختبر2026

    KPV attenuates adipogenesis and lipid metabolism through modulation of ROS-mediated AKT/mTORC1/PPARgamma signaling

    An SH, et al. · Tissue Cell · MDI-induced adipocyte differentiation in 3T3-L1 preadipocytes

    KPV dose-dependently suppressed adipocyte differentiation, with 100 ug/mL reducing Oil Red O staining intensity, through modulation of ROS-mediated AKT/mTORC1/PPARgamma signalling.

  13. 13في المختبر2026

    Lysine-proline-valine peptide attenuates hepatic lipid accumulation through ROS-dependent regulation of the PPARgamma pathway in HepG2 cells

    Lee JY, et al. · Cytotechnology · oleic acid-induced lipid accumulation in HepG2 hepatic epithelial cells

    KPV reduced oleic acid-induced lipid deposition and oxidative damage in HepG2 cells, with effects mapped to ROS-dependent regulation of the PPARgamma pathway and fatty acid synthase expression.

  14. 14في المختبر2025

    Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-kappaB pathway

    Sung J, et al. · Tissue Cell · human HaCaT keratinocytes exposed to fine particulate matter (PM10)

    PM10 suppressed HaCaT proliferation and induced a pro-inflammatory response; KPV mitigated the resulting apoptosis and inflammation by reducing oxidative stress and modulating MAPK/NF-kappaB signalling.

  15. 15في المختبر2000

    Antimicrobial effects of alpha-MSH peptides.

    Cutuli M, et al. · J Leukoc Biol · Staphylococcus aureus and Candida albicans cultures plus human neutrophils

    Alpha-MSH and its C-terminal tripeptide KPV inhibited S. aureus colony formation and reduced C. albicans viability and germ-tube formation across a broad concentration range, an effect linked to increased cAMP; neutrophil killing was not reduced.

  16. 16مراجعة2025

    Exploring the Role of Tripeptides in Wound Healing and Skin Regeneration: A Comprehensive Review

    Adnan SB, et al. · Int J Med Sci · review of tripeptides in wound healing and skin regeneration

    The review summarised how short peptides regulate cell migration, proliferation and differentiation during tissue repair, and noted that optimising outcomes in chronic wounds remains an unmet challenge.

  17. 17مراجعة2008

    Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases

    Brzoska T, et al. · Endocr Rev · review of alpha-MSH and related tripeptides across melanocortin receptor biology and immune-mediated inflammatory disease

    The review consolidated evidence that alpha-MSH and its C-terminal tripeptides exert protective and anti-inflammatory effects via central and peripheral melanocortin receptors and via direct effects on immune cells. It remains the standard mechanistic reference for KPV.

القيود

ما لا تثبته هذه الأدلة.

No human clinical trial of KPV has been published for colitis, wound healing, skin inflammation or any other indication, so effective human dose, route and safety profile are unknown. Free KPV is unstable in aqueous and rectal administration, which is why most recent work uses engineered delivery vehicles rather than the plain peptide sold to consumers; results from those formulations do not transfer to unformulated KPV.

أسئلة شائعة حول البحث.

What is KPV?

KPV is a three-amino-acid peptide — lysine, proline, valine — corresponding to residues 11–13 of alpha-melanocyte-stimulating hormone. It is the minimal C-terminal fragment of that hormone shown to retain anti-inflammatory activity in published models.

Why does the literature include oral protocols?

KPV is a substrate for PepT1, the di/tripeptide transporter expressed in intestinal epithelial and immune cells, so it can enter target cells after oral delivery. Colitis studies exploit that route directly.

How does KPV relate to alpha-MSH?

KPV is the C-terminal tripeptide of alpha-MSH. Research interest centres on the fact that it retains anti-inflammatory activity in models while lacking the pigmentary signalling of the full-length hormone, and that part of its effect appears to be independent of classical melanocortin-receptor signalling.

متاح من كتالوجنا

لأغراض البحث فقط. ليس للاستهلاك البشري أو التشخيص أو العلاج أو الوقاية من أي حالة. لا شيء في هذه الصفحة يعتبر نصيحة طبية، ولا ينبغي قراءة أي دراسة ملخصة هنا كتوصية.